KAL ELHOREGY, Director, Risk Evaluation and Mitigation Strategy (REMS) Programs, Amneal Pharmaceuticals

Kal Elhoregy is an accomplished healthcare industry executive with 24+ years’ experience focused on implementation of Risk Minimization Programs, Quality Management Systems (QMS) and Pharmacovigilance (PV) Compliance within the pharmaceutical industry. In his current role as a Director, Risk Evaluation and Mitigation Strategy (REMS), Regulatory Affairs Clinical at Amneal Pharmaceuticals, he manages all risk management programs and ensures the entity’s full compliance with risk management standards and guidelines.

As a strategist and accessible leader with experience in PV & Quality Risk Management (QRM), he helped multiple disciplines to effectively manage compliance risk in accordance with regulatory guidelines and increasing organizational capacity through streamlining complex processes.

He is a registered and licensed Pharmacist and holds a Bachelor of Science, Accounting from the Faculty of Commerce, Ain Shams University and Bachelor of Science of Pharmacy from Arnold & Marie Schwartz College of Pharmacy, Long Island University, New York.

His experience within the Health Care settings as a lead infusion Pharmacist, including Pediatric Intensive Care Units and Critical Care Unit Pharmacies. Also, his experience within the Pharmaceutical industry includes a strong expertise and leadership in PV Compliance, QRM and Quality System of PV, REMS, Risk Management Plan (RMP), GVP / CSV Risk Based Audit and Inspection Readiness.

Kal believes in leadership and teamwork and focuses on what is important to achieve successful results in ensuring patient safety and regulatory compliance.